Loading…
Reported covered position: LD, Rep. Cicilline- 2011-2012; LC, Rep. Hoyer-2009-2011; Policy Advisor, Rep. Baird 2007-2009; LC/LA,Rep. Boren- 2006-2007
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Domestic Violence Public Health Emergency Guidance Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program Discussions regarding pharmacy provider status legislation Discussions regarding support for the extention of the PREP Act Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding corporate sustainability initiatives Discussions in support of S. 1251, the Growing Climate Solutions Act Discussions in support of H.R. 2639, Trillion Trees Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2021 · third_quarter · Q3
Discussions regarding support for legislative solution for Deferred Action of Childhood Arrivals (DACA) Discussions related to Afghanistan Refugees and employment assistance.
Discussions regarding U.S. manufacturing commitment and supply chain policy
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Source: Senate LDA
Discussions regarding trade enforcement and tariff actions by the Administration Discussions regarding seasonal produce safeguard investigations Discussions related to trade and the environment Discussions regarding H.R. 4001, related to the enforcement of country-of-origin labeling on product listing pages
Discussions regarding corporate sustainability initiatives Discussions in support of S. 1251, the Growing Climate Solutions Act Discussions in support of H.R. 2639, Trillion Trees Act
Discussions regarding S.1260, The Endless Frontiers Act, related to trade and country of origin labeling requirements Discussions regarding responsible sourcing initiatives
Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program Discussions regarding pharmacy provider status legislation Discussions regarding support for the extention of the PREP Act Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions related to federal privacy legislation Discussions in support of INFORM Act (S.936) Discussions regarding online marketplace compliance program Discussions regarding SHOP SAFE Act
National Defense Authorization Act for Fiscal Year 2020
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding employees benefits innovations Advocacy related to TRICARE retail pharmacy pilot in National Defense Authorization Act (NDAA), H.R. 2500/S. 4049. Discussions related to COVID-19 testing and vaccine distribution preparation
Discussions regarding online marketplace compliance program Advocating for S.3431/H.R.7756, INFORM Act, legislation that would create transparency for customers on online marketplaces Discussions supporting S.3522, the Senior Scams Prevention Act and H.R. 2610, the Fraud and Scam Reduction Act
American Innovation and Manufacturing Leadership Act of 2020
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding corporate sustainability initiatives HFC legislation, H.R.5544 - American Innovation and Manufacturing Leadership Act of 2020 Discussions regarding renewable energy
Discussions related to the company's response to the Novel Corona Virus (Covid-19) pandemic. Discussions include policy guidance related to essential business operations, critical infrastructure, implementation and administration of economic stimulus, transportation, supply chain, immigration processing, investments in associates and commitment to hiring, and trade. H.R.6201 - Families First Coronavirus Response Act related to SNAP/WIC programs
Discussions regarding online marketplace compliance program Advocating for S.3431/H.R.7756, INFORM Act, legislation that would create transparency for customers on online marketplaces Discussions supporting S.3522, the Senior Scams Prevention Act and H.R. 2610, the Fraud and Scam Reduction Act
Discussions regarding online marketplace compliance program Advocating for S.3431/H.R.7756, INFORM Act, legislation that would create transparency for customers on online marketplaces Discussions supporting S.3522, the Senior Scams Prevention Act and H.R. 2610, the Fraud and Scam Reduction Act
National Defense Authorization Act for Fiscal Year 2021
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding employees benefits innovations Advocacy related to TRICARE retail pharmacy pilot in National Defense Authorization Act (NDAA), H.R. 2500/S. 4049. Discussions related to COVID-19 testing and vaccine distribution preparation
Discussions regarding online marketplace compliance program Advocating for S.3431/H.R.7756, INFORM Act, legislation that would create transparency for customers on online marketplaces Discussions supporting S.3522, the Senior Scams Prevention Act and H.R. 2610, the Fraud and Scam Reduction Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
United States-Mexico-Canada Agreement Implementation Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding World Trade Organization negotiations Discussions regarding passage of USMCA and H.R. 5430, legislation to implement USMCA
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding employee benefits innovations Discussions regarding Walmart's opioid stewardship policies Discussion regarding prescription drug price transparency Discussions regarding H.R.6, SUPPORT for Patients and Communities Act
Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
2021 · second_quarter · Q2
Discussions regarding trade enforcement and tariff actions by the Administration Discussions regarding seasonal produce safeguard investigations Discussions related to trade and the environment Discussions regarding H.R. 4001, related to the enforcement of country-of-origin labeling on product listing pages
Discussions regarding the individual tax treatment of employer-provided education benefits Discussions regarding tax policy
Discussions regarding corporate sustainability initiatives Discussions in support of S. 1251, the Growing Climate Solutions Act Discussions in support of H.R. 2639, Trillion Trees Act
Discussions supporting bipartisan policing reform
Discussions regarding U.S. manufacturing commitment/supply chain policy
Discussions regarding S.1260, The Endless Frontiers Act, related to trade and country of origin labeling requirements Discussions regarding responsible sourcing initiatives
Discussions providing overview of Walmart's responsible firearms sales practices
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding fair chance hiring practices and second chance hiring intiatives
Filing targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · Q1
Discussions regarding corporate sustainability initiatives Advocating for greater consumer choice in electricity markets
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding fair chance hiring
Discussions regarding trade enforcement and tariff actions by the Administration Discussions regarding World Trade Organization negotiations Discussions regarding seasonal produce safeguard investigations Discussions related to "buy America" and supply chain legislation
Discussions related to federal privacy legislation Discussions in support of INFORM Act (S.936) Discussions regarding online marketplace compliance program Discussions regarding SHOP SAFE Act
Discussions regarding business operations in Central America
Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program Discussions regarding pharmacy provider status legislation Discussions regarding support for the extention of the PREP Act Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Filing targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · fourth_quarter · Q4
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding the U.S.-UK FTA Discussions regarding Section 201 investigations into seasonal produce
Discussions regarding online marketplace compliance program Advocating for S.3431/H.R.7756, INFORM Act, legislation that would create transparency for customers on online marketplaces Discussions supporting S.3522, the Senior Scams Prevention Act and H.R. 2610, the Fraud and Scam Reduction Act
Discussions regarding corporate sustainability initiatives
Discussions regarding employees benefits innovations Discussions related to COVID-19 testing, vaccine administration and preparation including prioritization recommendations
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work
Discussions related to the company's response to the Novel Corona Virus (Covid-19) pandemic. Discussions include policy guidance related to transportation, supply chain, investments in associates and commitment to hiring, and trade in connection with COVID-19.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2020 · third_quarter · Q3
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work
Discussions regarding criminal justice/law enforcement reform
Discussions regarding corporate sustainability initiatives
Discussions related to the company's response to the Novel Corona Virus (Covid-19) pandemic. Discussions include policy guidance related to transportation, supply chain, investments in associates and commitment to hiring, and trade.
Discussions regarding employees benefits innovations Advocacy related to TRICARE retail pharmacy pilot in National Defense Authorization Act (NDAA), H.R. 2500/S. 4049. Discussions related to COVID-19 testing and vaccine distribution preparation
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation and entry into force of the USMCA (P.L.116-113) Discussions regarding the U.S.-UK FTA Discussions related to "buy America" and supply chain legislation
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Q2
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation and entry into force of the USMCA (P.L.116-113) Discussions related to tax issues on foreign markets Discussions regartding U.S.-Mexico customs issues
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work
Discussions regarding coin shortage
2020 · first_quarter · Q1
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation and entry into force of the USMCA (P.L.116-113)
Discussions regarding responsible sourcing initiatives in Asia Discussions related to Walmart operations in Chile
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding Fair Chance Hiring
2019 · third_quarter · 3A
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding World Trade Organization negotiations NAFTA/USMCA discussions regarding passage of USMCA
Discussions regarding corporate sustainability initiatives
2019 · fourth_quarter · Q4
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding Fair Chance Hiring
Discussions regarding corporate sustainability initiatives
Discussions regarding Walmart's opioid stewardship initiatives, including federal agency guidance Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640 Discussions regarding consumer healthcare innovations Discussions regarding proposals on healthcare access Discussions regarding Medicare reimbursement for telemedicine services
2019 · third_quarter · Q3
Discussions regarding corporate sustainability initiatives
Discussions regarding veteran and military spouse programs
Discussions regarding company's associate and consumer financial services offerings
2019 · first_quarter · 1A
Discussions regarding support for legislative solution for Deferred Action for Childhood Arrivals (DACA)
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Discussions regarding company's consumer financial services offerings
2019 · second_quarter · Q2
Discussions regarding infrastructure proposal and funding
Discussions regarding corporate sustainability initiatives
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding corporate share re-purchase programs and wages Discussions regarding fair chance hiring
2019 · first_quarter · 1A
Discussions regarding support for legislative solution for Deferred Action for Childhood Arrivals (DACA)
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding company's consumer financial services offerings
2019 · first_quarter · Q1
Discussions regarding company's consumer financial services offerings
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Discussions regarding support for legislative solution for Deferred Action for Childhood Arrivals (DACA)
2018 · fourth_quarter · Q4
Discussions regarding employee benefits innovations Discussions regarding Walmart's opioid stewardship policies Discussion regarding prescription drug price transparency Discussions regarding H.R.6, SUPPORT for Patients and Communities Act
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Maritime Commission, General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Discussions regarding criminal justice/law enforcement reform
Discussions related to the company's response to the Novel Corona Virus (Covid-19) pandemic. Discussions include policy guidance related to essential business operations, implementation and administration of economic impact payments, transportation, supply chain, investments in associates and commitment to hiring, and trade.
Discussions regarding support for legislative solution for Deferred Action for Childhood Arrivals (DACA) Modernization of Visa processing
Filing targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), Federal Motor Carrier Safety Administration, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Discussions related to the company's response to the Novel Corona Virus (Covid-19) pandemic. Discussions include policy guidance related to essential business operations, critical infrastructure, implementation and administration of economic stimulus, transportation, supply chain, immigration processing, investments in associates and commitment to hiring, and trade. H.R.6201 - Families First Coronavirus Response Act related to SNAP/WIC programs
Discussions regarding corporate sustainability initiatives HFC legislation, H.R.5544 - American Innovation and Manufacturing Leadership Act of 2020 Discussions regarding renewable energy
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Maritime Commission, Federal Motor Carrier Safety Administration, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions related to increasing the federal minimum wage
Discussions regarding company's associate and consumer financial services offerings
Discussions regarding veteran and military spouse programs
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding World Trade Organization negotiations Discussions regarding passage of USMCA and H.R. 5430, legislation to implement USMCA
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding World Trade Organization negotiations NAFTA/USMCA discussions regarding passage of USMCA
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions related to increasing the federal minimum wage
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding corporate share re-purchase programs and wages Discussions regarding fair chance hiring
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding U.S.-Mexico customs issues Discussions regarding World Trade Organization negotiations NAFTA/USMCA discussions regarding passage of USMCA
Discussions regarding support for legislative solution for Deferred Action for Childhood Arrivals (DACA)
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Discussions regarding company investment in associates including workforce training initiatives and future of work Discussions regarding fair chance hiring
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding company investment in associates including workforce training initiatives and future of work Discussions regarding fair chance hiring
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)